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ABSTRACT 
Background 
Type 2 diabetes and depression are two 
common chronic conditions affecting the Maltese 
population with significant and costly effects on 
health. Multiple studies have demonstrated 
a higher prevalence of depression in diabetic 
patients and a link with uncontrolled diabetes; 
however, despite this, depression is still not 
considered as important to chronic conditions 
in terms of the effects it has on health. 
Objectives 
This study was conducted to estimate the 
prevalence of depression in type 2 diabetic 
patients in primary care and to study their 
associated risk factors. 
Method 
A quantitative, cross-sectional, retrospective, 
descriptive study was performed among 400 
participants with type 2 diabetes attending 
diabetes clinics within the public health centres 
in Malta. Patients completed a self-administered 
questionnaire to quantify depressive symptoms 
and to study patient and disease characteristics. 
Convenience sampling was used to collect the 
data. 
Results 
Data analysis showed that the prevalence of 
depression is around 29.7% among type 2 
diabetic patients. Younger diabetics, women, 
lower educational levels, unemployment, obesity, 
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a family history of depression and uncontrolled 
diabetes were found to be associated with a 
higher risk of developing depressive symptoms. 
Conclusions 
Screening for depression in type 2 diabetic 
patients is important due to the high prevalence 
and significant impact on health. Appropriate 
management can significantly improve the 
outcome of both conditions and consequently 
im[prove both health and quality of life. 
Keywords 
Type 2 diabetes, depression, prevalence, primary 
care 
INTRODUCTION 
Diabetes and depression are two highly prevalent 
conditions in the Maltese population (Ministry 
for Social Policy, 2008) with studies showing that 
diabetic patients can be more prone to suffering 
from depression than the rest of the population 
(Cols-Sagarra, et al., 2016). 
In Malta, approximately 50,000 people, or 
13.2% of the population, between the ages of 
20 and 79 years suffer from type 2 diabetes 
(International Diabetes Federation, 2017), with 
approximately 10,000 people unaware of having 
the disease (Cuschieri, et al., 2016). Chronic 
depression affects around 20,000 people or 
5.1 % of the Maltese population (World Health 
Organization, 2016). The direct and indirect costs 
associated with the burden of both conditions 
can be staggering, especially when factoring in 
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the morbidity and mortality associated with these 
conditions if they are not well-treated (Ministry 
for Energy and Health - Health, 2014). Diabetes 
costs the Maltese public around 29 million euros 
per year, or 3.64% of the total health expenditure 
(Cuschieri, et al., 2016). While there is no data 
available for Malta, studies have shown that 
mental ill health costs developed countries in the 
European Union around 3-4% of the total health 
expendiiture (Gabriel and Liimatainen, 2000). 
Several studies have demonstrated a link 
between depression and chronic conditions. 
This often results in worsening of the patient's 
qua lity of life independently of the chronic 
condition on its own and an increased risk of 
developing complications (Cassano and Fava, 
2002; Chapman, Perry and Strine, 2005). 
It is possible to reverse the effect that 
depression has on diabetes by early recognition 
and adequate treatment of depression, either 
with psychopharmacological agents and/or 
psychotherapy, depending on the patients' 
characteristics and needs (Chapman, Perry and 
Strine, 2005). Despite several studies indicating 
a link between depression and poor control of 
diabetes, depression is still not considered to 
be as important as chronic health conditions 
in terms of the effect it has on general health 
(Moussavi, et al., 2007). 
The .aim of this study is to identify the type 
2 diabetic patients most likely to develop 
depression in a primary care setting. The 
objectives are to study the prevalence of 
depression and examine the associated factors 
in type 2 diabetic patients. 
METHOD 
A quantitative, cross-sectional, retrospective, 
descriptive study was carried out in a random 
sample of patients attending the diabetic clinics 
in the Mosta, Floriana and Paola health centres. 
The inclusion criteria included subjects older 
than 18 years, having an established diagnosis of 
type 2 diabetes, in a stable condition, those who 
consented to participate, and attended the clinic 
during the study period. Subjects having another 
type of diabetes or cognitive impairment, those 
attending other clinics in the health centre, 
and those who were unable to perform the 
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stLUdy, unstable oir refused to participate were 
excluded. The recruitment process was carried 
out between June and September 2018. A 
total of 400 questionnaires were collected , 
with 123 questionnaires collected from Mosta, 
151 questionnaires from Floriana and 126 
questionnaires from Paola Health Centre. Those 
that did not satisfy the inclusion criteria were 
excluded from the final number. 
Eth ical approva l from the Faculty and 
University of Malta Research Ethics Committees 
was obtained in addition to permission from the 
Data Protection Officer of the Primary HealthCare 
department. All patients taking part in the 
study gave consent after explanation of what 
the study entailed. The data was collected via a 
self-administered questionnaire and no study-
specific interventions were carried out. 
The questionnaire used consisted of a 
validated tool to measure depression, the Patient 
Health Questionnaire-9 (PHQ-9) (Kroenke, et al., 
2010), and a questionnaire developed by the 
author to quantify the patient sociodemographic 
and disease characteristics. These were 
translated to Maltese and peer-reviewed to 
reduce translation errors. A pilot study amongst 
17 subjects was carried out in Birkirkara Health 
Ceintre to improve the understandability of the 
questionnaires. 
The PHQ-9 was developed specifical ly to 
assess the severity of depression and monitor 
the effectiveness of treatment. It can also be used 
to make a tentative diagnosis of depression in 
populations at risk (Kroenke, Spitzer and Wil liams, 
2001 ). Scores of 0, 1, 2 and 3 are assigned to the 
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response categories: "not at all", "several days", 
"more than half the days" and "nearly every day" 
respectively. The total score ranges from 0 to 27, 
with the following scores: 0-4 (none), 5-9 (mild), 
10-14 (moderate), 15-19 (moderately severe) and 
20-27 (severe depression) (Kroenke, et al., 2010). 
The sociodemographic data collected included 
the age, gender, nationality, marital status, 
highest level of education, employment status 
and monthly income. Questions about general 
health included smoking status, weight and 
family history of diabetes and depression. The 
disease characteristics questions assessed the 
years with diabetes, medication used, medication 
compliance, the subjective and objective diabetic 
control and the presence of co-morbidities and 
diabetes complications. 
For descriptive analysis, the absolute (N) and 
relative (%) frequencies were used to describe 
qualitative variables. The non-parametric 
Kruskal-Wallis test was used to compare the 
mean depression scores between several 
independent groups, clustered by demographic 
variables, such as age and gender. Pearson's 
Chi-squared and Fisher's tests was used to assess 
the association between two categorical variables 
when using depression categories. A p-value 
of less than 0.05 was used to signify statistical 
significance. Data analysis was performed using 
the Statistical Package for Social Science (SPSS) 
program Version 25.0 (IBM Corp, 2017). 
RESULTS 
The mean age of all the participants was 69 years, 
and 54% of participants were men. Women were 
generally older and more morbidly obese, more 
likely to be widowed, worked at home, had a 
lower income and received minimal education. 
Men smoked more, were less comp!Uant with 
medication and had worse glucose control. 
Hypertension and dyslipidaemia were commoner 
in women, while myocard ial infarction and 
cerebrovascular accideints were more prevalent 
in men. Depression was commoner in women, 
with 37% of the female cohort having some 
degree of depression compared to 23.6% of the 
male cohort. 
An overview of the participants' characteristics 
according to gender can be viewed in Table 1. 
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Significant results for gender differences were 
obtained for marital status, the level of education 
and employment, smoking, the presence of co-
morbidities and complications, and the presence 
or absence of depression. Tables 2, 3 and 4 
detail the participants' characteristics according 
to presence of depression. The resu lts show 
that women andl younger diabetic patients 
had a higher risk of developing depression; 
same as those with a poorer educational level, 
those who had no job and were not pensioners, 
those who were obese and those with a family 
history of depression. The result of the 2-hour 
post-prandial capillary glucose test as reported 
by the participants, and the perceived diabetic 
control as measured by the participants' self-
rating of their usual control, were recorded. Both 
indicated that uncontrolled diabetes is a strong 
risk factor for development of depression. 
A summary of the p-values obtained from 
the results of the non-parametric Kruskal-Wallis 
and Chi-square tests used to study the statistical 
significance of different characteristics in the 
development of depression can be seen in Table 5. 
DISCUSSION 
Table 1 shows thatthe prevalence of depression 
in the Maltese diabetic popu lation is around 
29.7% (95% Confidence Interval: 25.4%-34.4%), 
which is comparable to a similar study by Cols-
Sagarra, et al. (2016) whereby the prevalence was 
29.2%. Similarly, a systematic review concluded 
that around a th ird of diabetics developed 
depression (Roy and Lloyd, 2012). 
Several international studies showed that 
women are more prone to developing depression 
than men (Cols-Sagarra, et al., 2016; Roy and 
Lloyd, 2012; Salintero-Fort, et al., 2018). This 
current study was concordant,. with 37% of 
fema le participants reporting depressive 
symptoms compared to 23.6% of men. Similarly, 
younger patients with diabetes reportedly were 
more at risk, possibly due to the increased co-
morbid disease in younger diabetics (Roy and 
Lloyd, 2012). Comparable results were replicated 
in this study with 39.1 % of those younger than 65 
years having depressive symptoms contrasting 
with 26.0% of thos.e 65 years or older. The exact 
figures can be observed in Table 2. 
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This study did not find any significant 
association between depressive symptoms and 
the nationality, possibly due to the much higher 
proportion of Maltese participants. A review 
of the literature did not provide any conclusive 
association between these factors, as few studies 
pointed towards a positive associati on while 
others failed to show any relation (Roy and Lloyd, 
2012; Salinero-Fort, et al., 2018). This hints at the 
idea that multiple factoirs are involved, including 
the possible genetic predisposition and the social 
status of immigrants in their new homeland (Roy 
and Lloyd, 2012). More detailed studies are 
required in this area to ful ly understand the effect 
of different nationalities on the development of 
depressive symptoms in diabetics. 
When reviewing local regional differences, 
no overall significance was found between the 
presence of depression and place where patients 
were reviewed. However, upon comparing with 
the PHQ-9 depression categories, a statistically 
significant result was obtained (p=0.006). Subjects 
reviewed in the northern region (Mosta) were 
found to have a higher risk for mild de[pression, 
while those in the central region (Floriana) had a 
higher prevalence of moderate and moderately-
severe depressive symptoms. Severe depression 
was commonest in the southern region served 
by Paola Health Centre, with 0.8% of participants 
followed closely by 0.7% in the region served by 
Floriana Health Centre (Figure 1 ). This could be 
explained by the socio-economic differences 
between the regions, where people living in 
the southern harbour region of Malta, which 
is served by Paola Health Centre, have a lower 
average household disposable income and 
higher unemployment rates than other regions 
(National Statistics Office, 2017). 
Lower level of education, unemployment, 
poor financial situation and the unmarried state 
were all positively associated with increased risk 
of depression (Engum, et al., 2005; Roy and Lloyd, 
2012). This study was concordant in relation 
to education and employment, whereby those 
with a low educational level and unemployment 
(including those who work at home or live on 
social benefits) had a higher risk of developing 
depression. The financial and marital status 
were however not statistically significant (Table 
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3). Evidence showed that poor social support is a 
known risk for depression (Roy and Lloyd, 2012); 
thus it might be that despite a poor financial 
situation and the unmarried state, the affected 
persons might still be receiving adequate social 
support, either from their close family and 
friends, or from state benefits. 
Obesity, smolking, and the presence of 
co-morbid diseases such as cardiovascular 
ischaemia, ce rebrovascu lar accidents, and 
retinopathy, all of which are associated with the 
development of diabetes, have been positively 
linked with an increased risk of depression 
(Engum, et al., 2005; Roy and Lloyd, 2012). The 
present study found statistica lly significant 
association with obesity only, and not with 
smoking and the presence of comorbidities and 
diabetic complications (Table 3). Similarly, the 
study by Col-Sagarra et al. (2016) did not find 
any association i111 this regard; however, there 
was a positive association with smoking and no 
correlation with obesity. These variations might 
reflect different methodologies for quantifying 
the different factors in each study, as there was 
more reliance on the subjects' interpretation of 
their general health in this study, while factors 
in the Spanish study more reliance was put on 
objective measurements when classifying weight 
and defining cardiovascular risk factors (Cols-
Sagarra, et al., 2016). 
Depressive symptoms were present in 44.8% 
of those reporting a family history of depression, 
while in those having a family history of diabetes 
the proportion was 29.8% (Table 3). Similarly, 
a study by Salinero-Fort, et al. (2018) reported 
a positive correlation with a family history of 
depression but not type 2 diabetes. Few studies 
have investigated the relationship between the 
duration of diabetes and the development of 
depression, which according to Salinero-Fort, et 
al., (2018) was found to be significant. This was 
not however replicated in this study, possibly 
due to recall bias. 
The study by Cols-Sagarra, et .al., (2016), did 
not find any significant difference between the 
use of different medication with depressive 
symptoms (p=0.07). Conversely, the current study 
showed that vildagliptin was associated with 
a higher prevalence of depressive symptoms. 
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Vildagliptin is common ly used as second or 
third-line treatment when other medications 
were not adequate to achieve good glycaemic 
control, indicating that hard-to-treat diabetes 
might increase the risk for depression. This 
was reflected strongly when investigating the 
subjective and objective glucose control, whereby 
subjects were asked to rate their usual glucose 
control and to quote their 2-hour post-prandial 
glucose finger pinprick test. The prevalence of 
depressive symptoms was higher in patnents with 
poor glycaemic control. These results were in 
concordance with other studies which showed 
that uncontrolled diabetes was associated with a 
higher prevalence of depressive symptoms (Roy 
and Lloyd, 2012; Salinero-Fort, et al. 2018). Table 
4 gives a more detailed review of these results. 
Study strengths 
The pilot study carried out helped to fine-tune 
the questionnaire and pre-empt problems prior 
to the main study. The large sample of 400 
participants chosen from the three main health 
centres helped ensure that there was a good 
cross-sectional representation of the population, 
while the validated PHIQ-9 questionnaire used 
allowed comparison with other studies in the 
literature. 
Study limitations 
When comparing the outcome of this study 
with other studies, the different methodologies 
utilized and limitations must be taken into 
consideration (Roy and Lloyd, 2012). Some of 
the limitations of this study include self-report 
and response bias, both of which depend on 
the subjects answering the questions honestly, 
and the Hawthorne effect, as the questionnaire 
was carried out in a waiting area with most 
subjects asking for the questions to be read out 
to them. Furthermore, recall bias needs to be 
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considered in questions requiring remembering 
certain information, while subjective questions 
depended on the subjects' interpretation of the 
question. Moreover, due to time and resource 
constraints, peripheral clinics and Gozo were 
excluded from the study, and convenience 
sampling was used. 
CONCLUSION 
Th is study determined the prevalence of 
depression in the local type 2 diabetic patients 
and those factors strongly associated with 
development of depressive symptoms. 
Increasing awareness of both health care 
professionals and the general population about 
depression and the risks it imposes on diabetic 
patients should be the first step so that effective 
action could be implemented. Furthermore, local 
structured guidelines can help to screen diabetic 
pat ients for depression. These recommendations 
can help to serve as guidance for GPs and other 
clinicians, policy makers, public health educators 
and researchers to improve the management of 
diabetic patients with depression. 
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Table 1: Overview of participants' characteristics according to gender 
Variable Total Males Females p-value N=400 N=216 N=184 
DEMOGRAPHIC INFORMATION 
Mean of Age (S.D; 69.0 (8.80; 68.4 (8.98; 67.2- 69.7 (8.54; 
0.150** 95% C.I.) 68.13-69.86) 69.61) 68.44-70.92) 
Age N{%) 0.126 
<65 years 115 (28.7%) 69 (60.0%) 46 (40.0%) 
>/= 65 years 285 (71.3%) 147 (51.6%) 138 (48.4%) 
Nationality N(%) 0.312* 
Maltes,e 391 (97.8%) 213 (54.5%) 176 (45.5%) 
Other 9 (2.3%) 3 (33.6%) 6 (66.7%) 
Marital Status N(%) <0.001* 
Single 39 (9.8%) 22 (56.4%) 17 (43.6%) 
Married 283 (70.8%) 66 (58.7%) 117 (41.3%) 
Separated 15 (3.8%) 11 (73.3%) 4 (26.7%) 
Divorced 7 (1.8%) 3 (42.9%) 4 (57.1%) 
Widowed 56 (14.0%) 14 (25.0%) 42 (75.0%) 
SOCIOECONOMIC STATUS 
Level of Education N(%) <0.001* 
Up to Primary School 188 (47.0%) 82 (43.6%) 106 (56.4%) 
Secondary School 152 (38.0%) 90 (59.2%) 62 (40.8%) 
Tertiary Education 56 (14.0%) 41 (73.2%) 15 (26.8%) 
Post-Tertiary 4 (1.0%) 3 (75.0%) 1 (25.0%) 
Education 
Employment Status N(%) <0.001 
Currently Working 41 (10.3%) 27 (65.9%) 14 (34.1%) 
Work at home/Depend 
on social benefits/ 86 (21.5%) 18(20.9%) 68 (79.1%) 
Don't Work 
Retired 273 (68.3%) 171 (62.6%) 102 (37.4%) 
Monthly Income N(%) *0.066 
<€800 331 (82.8%) 170 (51.4%) 161 (48.6%) 
€800-€1500 56 (14.0%) 38 (67.9%) 18 (32.1%) 
€1500 - €2500 12 (3.0%) 7 (58.3%) 5 (41.7%) 
> €2500 1 (0.3%) 1 (100.0%) 0 (0.0%) 
Region N(%) 0.908 
North 123 (30.8%) 66 (53.7%) 57 (46.3%) 
Central 150 (37.5%) 83 (55.3%) 67 (44.7%) 
South 127 (31.8%) 6 (52.8%) 60 (47.2%) 
GENERAL HEAL TH 
Smoking N(%) <0.001 
Never Smoked 220 (55%) 85 (38.6%) 135 (61.4%) 
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Variable Total Males Females p-value N=400 N=216 N=184 
Ex-Smoker 135 (33.8%) 94(69.6%) 41 (30.4%) 
Currently Smoking 45 (11.3%) 37 (82.2%) 8 (17.8%) 
Weight N(%) 0.213 
Not Obese 168 (42%) 95 (56.5%) 73 (43.5%) 
Obese 193 (48.3%) 105 (54.4%) 88 (45.6%) 
Morbidly Obese 39 (9.8%) 16 (41.0%) 23 (59.0%) 
Family History N(%) 0.714 
Type 2 Diabetes 319 (65.6%) 170 (53.3%) 149 (46.7%) 0.573 
Depression 96 (19.8%) 49(51.0%) 47 (49.0%) 0.505 
None 71 (14.6%) 42 (59.2%) 29 (40.8%) 0.337 
DISEASE CHARACTERISTICS 
Years w ith diabetes N(%) 0.943 
<5 years 108 (27.0%) 60 (55.6%) 48 (44.4%) 
5-10 years 107 (26.8%) 59 (55.1%) 48 (44.9%) 
10-15 years 91 (22.0%) 47 (51 .6%) 44(48.4%) 
>15 years 94 (23.5%) 50 (53.2%) 44 (46.8%) 
Medication Use N(%) 0.530 
Metformin 363 (59.7%) 201 (55.7%) 160 (44.3%) 0.057 
Gliclazide 171 (28.1%) 91 (52.6%) 82 (47.4%) 0.703 
Insulin 37 (6.1%) 17 (45.9%) 20 (54.1%) 0.302 
Vildagliptin 37 (6.1 %) 17 (45.9%) 20 (54.1%) 0.302 
Compliance N(%) 0.137 
Always took 322 (80.5%) 168 (52.2%) 154 (47.8%) 
medication 
Sometimes forgot 78 (19.5%) 48(61.5%) 30 (38.5%) 
Never took medication 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Subjective Diabetic Control N(%) 0.963* 
Very Good 36 (9.0%) 20 (55.6%) 16 (44.4%) 
Good 244(61.0%) 129 (52.9%) 115 (47.1%) 
Could be Better 111 (27.8%) 62 (55.9%) 49 (44.1%) 
Not Controlled 9 (2.3%) 5 (55.6%) 4 (44.4%) 
Objective Diabetic Cont rol N(%) 0.877 
<10 mmol/L 257 (64.3%) 139 (54.1%) 118 (45.9%) 
>/=1 O mmol/L 42 (10.5%) 24 (57.1 %) 18 (42.9%) 
Don't remember 101 (25.3%) 53 (52.5%) 48 (47.5%) 
Presence of Co-morbidities and Diabetic Complications N(%) 0.021 
Hypertension 299 (38.2%) 159 (53.2%) 140 (46.8%) 0.570 
Dyslipidaemia 278 (35.5%) 146 (52.5%) 132 (47.5%) 0.369 
Retinopathy 59 (7.5%) 36(61.0%) 23 (39.0%) 0.241 
Nephropathy 17 (2.2%) 8 (47.1%) 9 (52.9%) 0.557 
Neuropathy 12 (1.5%) 9 (75.0%) 3 (25.0%) 0.138 
Heart Disease 70 (9.0%) 51 (72.9%) 19 (27.1%) <0.001 
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Variable Total Males Females p-value N=400 N=216 N=184 
CVAorTIA 18 (2.3%) 12 (66.7%) 6 (33.3%) 0.270 
No Complications 29 (3.7%) 16 (55.2%) 13 (44.8%) 0.895 
DEPRESSION STATUS 
Presence/Absence of Depression N (%) 0.004 
No Depression 281 (70.3%) 165 (58.7%) 116(41.3%) 
Have Depression 119 (29.7%) 51 (42.9%) 68 (57.1%) 
Depression Category according to PHQ-9 N (o/o) 0.017* 
No Depression 281 (70.3%) 165 (58.7%) 116 (41.3%) 
Mild 81 (20.3%) 38 (46.9%) 43 (53.1%) 
Moderate 27 (6.8%) 10 (37.0%) 17 (63.0%) 
Moderately-Severe 9 (2.3%) 2 (22.2%) 7 (77.8%) 
Severe 2 (0.5%) 1 (50.0%) 1 (50.0%) 
*Fisher's Exact Test was used 
**Independent Sample t-test was used 
Table 2: Demographic information according to the presence of depression 
Variable Without Depression n= 281 With Depression n=119 p-value 
Mean of Age 69.72; 67.27; 0.011 ** (S.D; 9So/o C.I.) (8.62; 68.71 - 70.73) (9.00; 65.63-6.90) 
Age N{o/o) 0.009 
<65 years 70 (24.9%) 45 (39.1%) 
>/= 65 years 211 (75.1%) 74(26.0%) 
Gender N(o/o) 0.004 
Male 165 (76.4%) 51 (23.6%) 
Female 116 (63.0%) 68 (37.0%) 
Nationality N(o/o) 1.00* 
Maltese 274(70.1%) 117 (29.9%) 
Other 7 (77.8%) 2 (22.2%) 
Marital Status N(o/o) 0.119* 
Single 33 (84.6%) 6 (15.4%) 
Married 199 (70.3%) 84(29.7%) 
Separated 8 (53.3%) 7 (46.7%) 
Divorced 5 (71.4%) 2 (28.6%) 
Widowed 36 (64.3%) 20 (35.7%) 
* Fisher's Exact Test was used due to small numbers 
** Independent Samples t-test was used to calculate the p-values to assess any significant difference between 
the mean of age of those not depressed and those depressed 
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Table 3: Socioeconomic status and general health characteristics according to the 
presence of depression 
Variable Without Depression With Depression p-value 
n= 281 n=119 
Level of Education N(%} 0.013* 
Up to Primary School 123 (65.4%) 65 (34.6%) 
Secondary School 106 (69.7%) 46 (30.3%) 
Tertiary Education 48 (85.7%) 8 (14.3%) 
Post-Tertiary Educatioin 4(100%) 0 (0%) 
Employment Status N(o/o} 0.010 
Currently Working 31 (75.6%) 10 (24.4%) 
Work at home/Depend on social 49 (57.0%) 37 (43.0%) 
benefits/ Don't Work 
Retired 201 (73.6%) 72 (26.4%) 
Monthly Income N(o/o} 0.080* 
<€800 224 (67.7%) 107 (32.3%) 
€800 - €1500 46(82.1 %) 10 (17.9%) 
€1500 - €2500 10 (83.3%) 216.7%) 
> €2500 1 (100%) 0 (0%) 
Region N(%} 0.807 
North 85 (69.1 %) 38 (30.9%) 
Central 104 (69.3%) 46 (30.7%) 
South 92 (72.4%) 35 (27.6%) 
Smoking N(%} 0.609 
Never Smoked 159 (72.3%) 61 (27.7%) 
Ex-Smoker 92 (68.1 %) 43 (31.9%) 
Currently Smoking 30 (66.7%) 15 (33.3%) 
Weight N(o/o} 0.001 
Not Obese 133 (79.2%) 35 (20.8%) 
Obese 127 (65.8%) 66 (34.2%) 
Morbidly Obese 21 (53.8%) 18 (46.2%) 
Family History N(%} 0.016 
Type 2 Diabetes 224 (70.2%) 95 (29.8%) 0.979 
Depression 53 (55.2%) 43 (44.8%) <0.001 
None 51 (71.8%) 20 (28.2%) 0.748 
* Fisher's Exact Test was used due to small numbers 
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Table 4: Disease characteristics of participants according to the presence of depression 
Variable Without Depression With Depression p-value 
n= 281 n=119 
Years with diabetes N(%) 0.826 
<5 years 80 (74.1 %) 28 (25.9%) 
5-10 years 78 (72.9%) 29 (27.1%) 
10-15 years 58 (63.7%) 33 (36.3%) 
>15 years 65 (69.1%) 29 (30.9%) 
Medication Use N(%) 0.074 
Metformin 254(70.4%) 107 (29.6%) 0.804 
Gliclazide 113 (65.3%) 60 (34.7%) 0.051 
Insulin 21 (56.8%) 16 (43.2%) 0.059 
Vildagliptin 20 (54.1%) 17 (45.9%) 0.024 
Compliance N(%) 0.826 
Always took medication 227 (70.5%) 95 (29.5%) 
Sometimes forgot 54 (69.2%) 24 (30.8%) 
Never took medication 0 (0.0%) 0 (0.0%) 
Subjective Diabetic Control N(%) <0.001 
Very Good 27 (75.0%) 9 (25.0%) 
Good 190 (77.9%) 54 (22.1 %) 
Could be Better 58 (52.3%) 53 (47.7%) 
Not Controlled 6 (66.7%) 3 (33.3%) 
Objective Diabetic Control N(%) 0.002 
<10 mmol/L 192 (74.7%) 65 (25.3%) 
>/=1 o mmol/L 20 (47.6%) 22 (52.4%) 
Don't remember 69 (68.3%) 32 (31.7%) 
Presence of Co-morbidities and Diabetic Complications N(%) 0.303 
Hypertension 207 (69.2%) 92 (30.8%) 0.443 
Dyslipidaemia 183 (65.8%) 95 (34.2 %) 0.003 
Retinopathy 35 (59.3%) 24 (40.7%) 0.047 
Nephropathy 9 (52.9%) 8 (47.1%) 0.111 
Neuropathy 6 (50.0%) 6 (50.0%) 0.119 
Heart Disease 40 (57.1%) 30 (42.9%) 0.008 
CVAor TIA 11(61.1%) 7 (38.9%) 0.385 
No Complications 23 (79.3%) 6 (20.7%) 0.268 
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Table 5: The p-values for the Kruskal-Wallis and Chi-square tests comparing the mean 
Depression Score, the PHQ-9 depression categories and the Presence of Depression 
against No Depression 
PHQ-9 PHQ-9 
Presence of 
Factor Mean Depression Depression Depression Scores Categor ies (Chi-Squared Test) (Kruskal-Wallis Test) (Chi-Squared Test) 
Gender <0.001 0.027 0.004 
Age 0.04 0.027 0.009 
Nationality 0.169 0.915 0.617 
Region 0.590 0.006 0.807 
Marital status 0.484 0.387 0.143 
Highest level of 0.025 0.49 0.017 
education attended 
Employment status 0.001 0.05 0.010 
Financial status 0.183 0.592 0.100 
Smoking 0.509 0.348 0.609 
Weight <0.001 0.007 0.001 
Family history of 
type 2 diabetes and 0.005 <0.001 0.003 
depression 
Years with type 2 
0.39 0.587 0.826 diabetes 
Medication in use 0.081 0.059 0.074 
Medication 
0.794 0.806 0.826 
compliance 
Subjective diabetic 
<0.001 <0.001 <0.001 
control 
Objective diabetic 0.001 0.012 0.002 
control 
Co-morbidities and 0.070 0 .. 914 0.303 
complications 
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